Molecular and metabolic insights of creatine supplementation on resistance training
Perspectivas moleculares y metabólicas de la suplementación con creatina en el entrenamiento de fuerza
DOI:
https://doi.org/10.15446/rev.colomb.quim.v44n1.53978Palabras clave:
Cr/PCr/CK System, creatine monohydrate, muscle energy metabolism, MAPK, IGF-I, resistance training, highintensity exercise (en)sistema Cr/PCr/CK, monohidrato de creatina, metabolismo energético muscular, MAPK, IGF-I, entrenamiento de fuerza, ejercicio de alta intensidad (es)
Descargas
DOI: https://doi.org/10.15446/rev.colomb.quim.v44n1.53978
Molecular and metabolic insights of creatine supplementation on resistance training
Perspectivas moleculares y metabólicas de la suplementación con creatina en el entrenamiento de fuerza
Perspectivas moleculares e metabólicas da suplementação de creatina no treinamento de força
Diego A. Bonilla1,*, Yurany Moreno1
1 Department of Biochemistry and Molecular Biology, Universidad Distrital Francisco José de Caldas, Bogotá D.C. 110311, Colombia. / +57 317 7555184
* Autor de correspondencia: dabonilla@g-se.com
Article citation:
Bonilla, D. A.; Moreno, Y. Molecular and metabolic insights of creatine supplementation on resistance training. Rev. Colomb. Quim. 2015. 44(1), 11-18. DOI: https://doi.org/10.15446/rev.colomb.quim.v44n1.53978
Recibido: 11 de Febrero de 2015. Aceptado: 5 de marzo de 2015
Abstract
In recent years the research problem in the field of sports supplementation has changed to explain the metabolic mechanisms by which creatine (Cr) administration enhances the performance of certain sports or simply benefits the muscular adaptation. In this review for first time the biochemical mechanisms of Cr ingestion in a cell signaling insight were analyzed, focusing on energetic bioavailability enhancement and optimization of the temporal and spatial buffering of Cr/PCr/CK system. Moreover, intensification in proliferation and differentiation processes of muscle cells (IGF-I/PI3K/Akt-PKB, SPHK1/MAPK/p38/MRFs, mTOR, cellular swelling, mitotic activity of satellite cells, actin polymerization, and myoblast fusion) and inactivation and/or reduction in the expression of ergolitic metabolites (GSK3β, myostatin and AMPK regulation) were examined. In this way, we explained from a metabolic point of view the increase in muscle mass, strength, fatigue resistance, and performance of high intensity sports after Cr monohydrate supplementation.
Keywords: Cr/PCr/CK System, creatine monohydrate, muscle energy metabolism, MAPK, IGF-I, resistance training, high-intensity exercise.
Resumen
En los últimos años el problema de investigación en el campo de la suplementación deportiva ha cambiado al punto de explicar los mecanismos metabólicos por los cuales la administración de creatina (Cr) incrementa el rendimiento en ciertos deportes o simplemente beneficia la adaptación muscular. Esta revisión analiza por primera vez los mecanismos bioquímicos de la ingesta de Cr desde la perspectiva de señalización celular, enfocándose en la mayor biodisponibilidad energética de Cr y optimización de la acción buffer espacial/temporal que ofrece el sistema Cr/PCr/CK. Además, se examinan aspectos relacionados con el incremento en los procesos de proliferación y diferenciación de células musculares (IGF-I/PI3K/Akt-PKB, SPHK1/MAPK/p38/MRFs, mTOR, hinchamiento celular, actividad mitótica de células satélite, polimerización de actina y fusión de mioblastos) y la inactivación y/o reducción en la expresión de proteínas con funciones ergolíticas (GSK3β, miostatina y regulación de AMPK). De esta manera, se explican el aumento de la masa muscular, la fuerza, la resistencia a la fatiga y el rendimiento en ejercicios de alta intensidad, producidos por la suplementación con monohidrato de Cr, desde un punto de vista metabólico.
Palabras Clave: sistema Cr/PCr/CK, monohidrato de creatina, metabolismo energético muscular, MAPK, IGF-I, entrenamiento de fuerza, ejercicio de alta intensidad.
Resumo
Nos últimos anos, o problema de pesquisa no campo da suplementação de esportes mudou ao ponto de explicar os mecanismos metabólicos pelos quais a administração de creatina (Cr) aumenta o desempenho em alguns esportes ou benefícios de adaptação musculares. Neste artigo, vamos analisar primeiro os mecanismos bioquímicos de ingestão da Cr a partir da perspectiva de sinalização celular, com foco em maior biodisponibilidade de energia de Cr e otimização de tampão temporais/espacial ação oferecida pelo sistema Cr/PCr/CK. Além disso, são considerados aspectos relacionados com o aumento da os processos de proliferação e diferenciação de células musculares (IGF-I/PI3K/Akt-PKB, SPHK1/MAPK/p38/MRFs, mTOR, inchaço celular, atividade mitótica da célula satélite, a polimerização de actina e de fusão de mioblastos) e inativação e/ou a redução na expressão de proteínas com funções ergolíticas (GSK3, miostatina e regulação da AMPK). Desta maneira, é explicado o aumento da massa muscular, força, resistência à fadiga e desempenho em exercícios de alta intensidade, produzidos pela suplementação com Cr monohidratada, a partir de um ponto de vista metabólico.
Palavras-chave: sistema Cr/PCr/CK, creatina monohidratada, metabolismo energético muscular, MAPK, IGF-I, treinamento de força, treinamento de alta intensidade.
Introduction
Creatine (Cr) was discovered in 1832 by the French scientist Michel Eugene Chevreul, who extracted from meat a new organic constituent and named it creatine, from Greek κρέας = kreas flesh (1). Cr or N-(aminoiminomethyl)-N-methyl-glycine (CAS 57-00-1, 2006) is a metabolite with a molecular dimension similar to an amino acid (2) which is synthesized mainly in liver, kidney, and pancreas (3). Endogenous synthesis of Cr starts with the transfer of the amidino group of arginine to the amino group of glycine by L-Arginine-Glycine amidinotransferase (AGAT - EC 2.1.4.1) yielding L-ornithine and guanidinoacetate (3). Then, guanidinoacetate is methylated at the original nitrogen of glycine using S-adenosylmethionine as donor of the methyl group. This reaction produces Cr and S-adenosylhomocysteine and is catalyzed by Guanidinoacetate N-Methyltransferase (GAMT - EC 2.1.1.2) (Figure 1) (4, 5).
On the other hand, Cr is degraded spontaneously through a monomolecular reaction to creatinine (Crn, MW 113.1 g/mol), which is quantitatively excreted in the urine (6). The rate of excretion is estimated about 1.7% of the total Cr (TCr) body pool per day (7). Cr is primarily present in cells with high and intermittent energy (8). However, the tissues that store the highest concentrations of this metabolite do not synthesize it on their own but obtain it Cr from the bloodstream via a specific carrier (CreaT), nowadays denominated as SLC6A8 (9, 10, 11). Near 95% of the Cr reserves in the body are found in skeletal muscle and the other 5% remaining is distribute in heart, brain, liver, kidney, testicles, retina, and epithelial cells (8, 9, 12, 13). The average concentration of Cr in muscle tissue is 120 mmol/kg dry-mass (4). In muscle, Cr is found in a ∼33% in natural form and the ∼67% remaining in form of phosphocreatine (PCr), the energetically loaded form via creatine kinase (CK-EC 2.7.3.2), hence acting as a cellular buffer on H+ ions (Figure 2).
High-energy phosphates, as PCr, provide the necessary energy for muscle contraction to the start-up of the activity and during explosive, short and high intensity exercise. In the periods of muscular inactivity, PCr is rapidly resynthesized, paradoxically this process requires the energy precedent of ATP hydrolysis from aerobic systems (14, 15).
Cr crystallizes from water as monoclinic prisms holding one molecule of water of crystallization per molecule of Cr (2), forming the popular dietary supplement known as Cr monohydrate, which makes part of the most frequent nutritional supplements used by amateur and elite athletes due to its ratified ergogenic effects on resistance training (16-27). However, the metabolic principles that explain the positive effects of Cr supplementation on athletic performance remains less understood currently.
Creatine supplementation on fatigue resistance
The main event after Cr ingestion is the increase in serum and muscular Cr levels, without variations on ATP concentrations (24, 28, 29). For example, in response to higher doses (20 g Cr), serum Cr concentration increased by 50-fold (peak value of serum Cr is approximately 2.17 ± 0.66 mM) 2.5 hours after ingestion. However, in response to lower doses (< 2 g Cr), the blood increase in Cr is insignificant (30). In skeletal muscle, Cr and PCr concentrations, before supplementation, are approximately 85 and 41 mmol/kg dry mass respectively, which equals to an intracellular TCr concentration of 40-50 mM (100-150 mmol/kg dry mass). Nevertheless, TCr levels increase by about 25% after Cr supplementation (31), and 37% if the Cr ingestion is accompanied of exercise (29). In this sense, it has been reported that Cr supplementation increases muscle PCr content approximately by 20%, generally from 70-90 to 85-105 mmol/kg dry mass (32). Accordingly, this suggests that the PCr/TCr ratio (do not confuse with the PCr/Cr ratio) diminishes after Cr supplementation at rest. Assuming equilibrium of the CK reaction, this decrease in PCr/TCr implies increased cytoplasmic ADP and decreased Gibbs free energy of ATP hydrolysis in muscle, which seems contrary to the reported ergogenic benefits of Cr supplementation. However, Brault et al. (33) showed that muscle concentrations of PCr and TCr increased linearly throughout 5 days of Cr supplementation (0.43 g/kg body mass/day) using 31P and 1H magnetic resonance spectroscopy (MRS). These results indicate that Cr supplementation does not alter the PCr/TCr ratio and hence the Gibbs free energy of ATP hydrolysis in muscle at rest. Indeed, during Cr supplementation the TCr muscle levels keep its normal homeostasis due to the increment in PCr and Cr by ∼70% and ∼30%, respectively. Meyer's (34) "electrical analog" model of respiratory control posits that the time constant (τ) for the exponential fall in muscle PCr concentration following the onset of muscle contractions is a function of the mitochondrial resistance and the metabolic capacitance. This capacitance leads to reduction of peak rates of ATP synthesis in cells with fluctuating energy consumption. Moreover, the capacitance allows repayment of energy "debt" during stages of high energy demand to occur between periods of low rates of energy consumption. The CK reaction concedes myocytes to sustain reduced mitochondrial volume, aid larger diameter fibers, and express faster isoforms of myosin (15). The Meyer's model predicts that an increase in mitochondrial density will result in a shorter τ (that is, faster PCr concentration, [PCr], kinetics) and that an increase in metabolic capacitance, determined predominantly by the muscle TCr content, will result in a longer τ (slower [PCr] kinetics) (35), and therefore benefits short duration high-intensity exercise. Currently, it is established that PCr concentration and VO2 vary with similar kinetic profiles from the start-up of the exercise until a new state of energy production by oxidative metabolism. This data display that regulation of mitochondrial respiration is intimately linked to ATP/ADP and PCr/Cr ratios, by means of CK reaction (36). Jones et al. (35) developed a study to analyze the effect of Cr supplementation (20 g/day x 5 days) on [PCr] kinetics using 31P MRS, following the onset and offset of both moderate-intensity and heavy-intensity exercise.
The results showed that Cr administration increments by ∼8% the PCr/ATP relation consistent with the muscle TCr increase. Furthermore, τ for [PCr] was enhanced after Cr loading phase for moderate exercise and subsequent recovery and for heavy exercise but not for subsequent recovery. These data demonstrate, for the first time in humans, that an increase in muscle [PCr] results in a slowing of [PCr] dynamics in exercise and subsequent recovery.
Cr supplementation, besides regulating the muscular ATP and ADP concentrations, enhances myocellular PCr levels generating an increase in τ for [PCr] by means of a higher energy bioavailability of the CK system. This implies that ergogenic effects of Cr supplementation can be sustained from enhanced kinetic variables of PCr degradation process. Moreover, the augment of [PCr] generates a longer dependence of high energy phosphates metabolism to produce energy in a fast and effective way, also permitting less accumulation of fatigue-linked molecules as:
1. Inorganic Phosphate (Pi) and Hydrogen Ion (H+): During short periods of high-intensity exercise, Pi and H+ are accumulating within skeletal muscle originating apparition of fatigue through several mechanisms (37, 38). Cr supplementation has been shown to diminish the concentration of H+ (30, 35, 39, 40) and Pi (39, 41). These phenomena also lead to less hypoxanthine accumulation (30, 42, 43).
2. Cytosolic Ca2+ concentration: High Ca2+ concentrations due to energy deficiency and less sarcoplasmic reticulum uptake during exercise are strongly associated with fatigue (44, 45, 46). Cr administration seems to improve the Ca2+ uptake by sarcoplasmic reticulum Ca2+-ATPase and parvalbumin (47, 48), while regulates the Ca2+ release during the excitation-coupling process (49, 50).
Creatine supplementation in the increasing lean body mass and muscle strenght
Increment of muscle protein synthesis is one of the Cr supplementation effects after resistance training, although it has converted an important point of debate due to tuneless findings of some investigations (51, 52). Nevertheless, since more than two decades many studies have revealed that Cr supplementation accompanying a period of resistance training increases muscle fibers size with respect to control subjects (53, 54, 55, 56, 57). In addition, in vitro studies have shown an increment in myotubes diameter after Cr exposition with regard to controls (58, 59, 60). However, a molecular point of view is needed in order to explain the myocellular responses to Cr supplementation, generally involving larger cross-sectional area and subsequent lean body mass and strength gain.
Nutrient, hormonal, and contractile stimuli often (but not always) converge at mammalian target of rapamycin (mTOR), suggesting that this protein is an important modulator of protein synthesis (61). mTOR is part of two multiprotein complexes; mTORC1, which activates downstream S6 kinase (S6K, also known as p70s6k, which in turn phosphorylates the ribosomal protein S6 and other factors involved in translation, initiation and elongation stimulating protein synthesis) and phosphorylates the inhibitory eukaryotic initiation factor 4E binding protein (4E-BP1); and mTORC2, which phosphorylates Akt (also called protein kinase B, PKB) at serine 473, this phosphorylation is required for maximum activation of Akt, thus regulating protein synthesis (62). Some investigations have analyzed the effect of Cr supplementation towards the proteins involved in the mTOR signaling pathway. Deldicque et al. (63) evaluated in a double-blind cross-over design the phosphorylation state of S6K1 and 4E-BP1 after Cr supplementation (21 g/day x day) in six men following 10 sets of 10 leg-press repetitions (every 5 s) at 70% of each individual 1-RM, and found that three hours post-exercise the phosphorylation state of S6K1 increased by about 400% in both groups. However, the phosphorylation state of S6K1 returned to basal values 24 h post-exercise and Cr had no additional effect. In this way, the results of these investigations show that Cr supplementation has no effect on phosphorylation state of S6K1; notwithstanding, the association of S6K1 phosphorylation and muscle mass was demonstrated in human subjects after 12-weeks of resistance training; thus, it should be necessary the evaluation of long-term Cr supplementation on S6K1. On the other hand, though exits a potential Cr inhibition on 4E-BP1, it is important to stand out that 4E-BP1 phosphorylation is reduced during resistance exercise and is unchanged during post-exercise recovery. Thus, it appears that the contraction-induced increase in muscle protein synthesis is independent of changes in 4E-BP1 phosphorylation (61).
It has been demonstrated that Akt/PKB can activate directly the mTORC1 complex by phosphorylation on raptor or indirectly by means of phosphorylation and inhibition of the tuberous sclerosis complex (TSC) proteins 1 and 2 (62), moreover another novel negative regulator of mTORC1 is proline-rich Akt substrate-40 (PRAS40), which has been shown to bind mTOR via raptor to repress mTORC1 signaling. The inhibitory function of PRAS40 is reduced when phosphorylated by Akt/PKB (61). Additionally, mTORC1 is also positively regulated for amino acids, mainly leucine, by means of the vacuolar protein sorting-34 (Vps34) and mitogen activated protein kinase kinase kinase kinase-3 (MAP4K3) (64). Finally, since synthesizing proteins is an energetically expensive cellular process, it is not surprising to find a specific regulator of mTORC1 function when energy is not sufficient. Indeed, mTORC1 has been shown to be inhibited by AMP-activated protein kinase (AMPK) through enhanced TSC2 activity and, recently, by phosphorylating raptor (61). Evidence suggests that Cr supplementation regulates the above upstream mTOR processes as we describe next.
Deldicque et al. (63) evaluated the effect of Cr supplementation (21 g/day x 5 days) on IGF-I and IGF-II mRNA expression pre and post-exercise in biopsies from vastus lateralis throughout RT-PCR, and found that in Cr group IGF-I and IGF-II mRNA expression at rest was increased by 30% and 46% than placebo, respectively. However, the mRNA expression measured after exercise was similar for the Cr and the placebo conditions. Burke et al. (65) reported a significant increase in intramuscular IGF-I concentration in Cr supplemented athletes (0.25 g Cr/kg mass dry x 7 days followed of 0.06 g Cr/kg mass dry x 49 days) following an 8 weeks-program of resistance training. In agreement with this, Snow et al. (66) determined the effects of Cr supplementation (0.8 g/kg body mass) and moderate intensity resistance training on the phosphorylation state of some proteins involved in the Akt/PKB pathway, finding that the phosphorylation state of Akt/PKB and GSK3β increased significantly in Cr supplemented group at 1 and 5 days. Safdar et al. (67) reported an increment in mRNA (2.1 fold) and protein (4.2 fold) content of Akt/PKB after Cr supplementation (20 g/day x 3 days followed of 5 g/day x 7 days) without changes in placebo group. Furthermore, Cr administration reduces the leucine oxidation rate and flux ratio mitigating the protein catabolism in men (68) and at the same time generates a greater bioavailability of arginine and L-homoarginine in the body (69), which correlates with NO production during exercise. Although there is not enough scientific support in humans, some authors claim that Cr supplementation and its inherent increased PCr/Cr ratio could inactivate the AMP-activated protein kinase (AMPK) since it was shown in vitro that high PCr concentrations reduce AMPK activity to 50% which means this kinase is sensitive not only to ATP/AMP but also to PCr/Cr ratio (70).
In this way, the increasing lean body mass after Cr supplementation can be related to the stimulation of signaling pathways as IGF-I, mainly PI3K/Akt-PKB/mTOR which plays an important role in the regulation of muscular hypertrophy, and the probable leucine and AMPK regulation on mTOR. Stepping aside the direct effect of Akt/PKB on mTOR regulation, a novel mechanism mediating the effect of GSK3β on muscle growth has been described recently. GSK3β is able to phosphorylate nebulin localized to the Z-disk, thus preventing the interaction of nebulin with neuronal Wiscott-Aldrich syndrome protein (NWASP), which is involved in actin assembly (62). Therefore, IGF-I/Akt-PKB signaling controls myofibril growth and maintenance via the GSK3β/nebulin/N-WASP pathway. This phenomenon could explain the findings of some researchers years ago. Dangott et al. (71) and Olsen et al. (72) showed that Cr supplementation increase the satellite cell population and its mitotic activity, while O'connor et al. (59) showed that Cr stimulates the myoblast fusion in vitro and in vivo possibly mediated by actin polymerization.
In general, most of the investigations on Cr supplementation have reported an increase in the intracellular volume without notorious changes in extracellular volume (67, 73, 74, 75, 76), probably because of the high osmotic charge associated to the increase in Cr and Na+ in cytosol. In fact, cell swelling has been marked as an anabolic signal (77), which in turn can stimulate the activation of osmosensing molecules as G protein coupled receptors in the MAPK pathway and sphingosine kinase (SPHK1), creating a positive feedback motif. This osmotic effect of Cr supplementation on SHPK1 and the MAPKs p38 and ERK6 was confirmed by Safdar et al. (67) as well as other studies have shown a p38 overexpression after in vitro (58) and in vivo (79) Cr administration. Activation of MAPKs is crucial for muscle adaptations and development after exercise (80). For example, JNK/SAPK is involved in the transcription process of CK via p53 whereas p38 plays an important role in the up-regulation of Myogenic Regulatory Factors (MRFs) and myostatin down-regulation (81). MRFs are transcription factors involved in the differentiation and maintenance processes of muscle cells with multiple regulation points throughout the myogenic lineage (these include the proteins MyoD, Myogenin, Myf5, and MRF4/Myf6/Herculin), regulating the expression of important proteins such as CK and Myosin Heavy Chain (82). Particularly, Cr supplementation has safe (84) and conserved effects on increasing MRFs expression (mRNA and protein) even with different administration protocols in humans (55, 83, 85, 86).
In particular, Cr supplementation during an exercise training program can increase the muscle mass and strength (87) by means of positive regulation processes, which include the higher IGF-I and IGF-II expression and following turning on of the well-established Akt/GSK3β/mTOR signaling pathway and the SHPK1/MAPK/MRF pathway and its downstream components activation by means of the creatine-induced cell swelling (all features pictured in Figure 3).
Conclusion
In summary the ergogenic effects of Cr supplementation are absolutely dependent upon Cr accumulation in myocyte and the subsequent optimization of the Cr/PCr/CK system which serves as a spatial/temporal buffer of ATP regeneration in proximity to myocelullar ATPases. In addition, this improvement in energy homeostasis leads to positive regulation of anabolic hubs (such as IGF-I and MAPK), which stimulate synergically the faster muscle growth and strength gain.
References
1. Williams, M.; Kreider, R.; Branch, J. Creatine: The power supplement. Human Kinetics: Leeds, UK, 1999; pp 6-7.
2. Pischel, I.; Gastner, T. Creatine - its chemical synthesis, chemistry and legal status. Subcell. Biochem. 2007, 46, 275-289. DOI: https://doi.org/10.1007/978-1-4020-6486-9_15.
3. Brosnan, M.; Brosnan, J. Creatine: Endogenous metabolite, dietary and therapeutic supplement. Annu. Rev. Nutr. 2007, 27, 241-261. DOI: https://doi.org/10.1146/annurev.nutr.27.061406.093621.
4. Stout, J.; Antonio, J.; Kalman, D. Essentials of creatine in sports and health. Humana Press Inc.: Totowa, NJ, 2008; pp 30-40. DOI: https://doi.org/10.1007/978-1-59745-573-2.
5. da Silva, R.; Nissim, I.; Brosnan, M.; Brosnan, J. Creatine synthesis: Hepatic metabolism of guanidinoacetate and creatine in the rat in vitro and in vivo. Am. J. Physiol. Endocrinol. Metab. 2009, 296, 256-261. DOI: https://doi.org/10.1152/ajpendo.90547.2008.
6. Uzzan, M.; Nechrebeki, J.; Zhou, P.; Labuza, T. Effect of water activity and temperature on the stability of creatine during storage. Drug Dev. Ind. Pharm. 2009, 35(8), 1003-1008. DOI: https://doi.org/10.1080/03639040902755197.
7. Wyss, M.; Kaddurah-Daouk, R. Creatine and creatinine metabolism. Physiol. Rev. 2000, 80, 1107-1213.
8. Wallimann, T.; Tokarska-Schlattner, M.; Schlattner, U. The creatine kinase system and pleiotropic effects of creatine. Amino Acids. 2011, 40, 1271-1296. DOI: https://doi.org/10.1007/s00726-011-0877-3.
9. Snow, R.; Murphy, R. Creatine and the creatine transporter: A Review. Mol. Cell. Biochem. 2001, 224, 169-181.
10. Peral, M.; García-Delgado, M.; Calonge, M.; Durán, J.; De La Horra, M.; Wallimann, T.; Speer, O.; Ilundáin, A. Human, rat and chicken small intestinal Na+-Cl- creatine transporter: Functional, molecular characterization and localization. J. Physiol. 2002, 545(1), 133-144.
11. Christie D. Functional insights into the creatine transporter. Subcell. Biochem. 2007, 46, 99-118. DOI: https://doi.org/10.1007/978-1-4020-6486-9_6.
12. Speer, O.; Neukomm, L.; Murphy, R.; Zanolla, E.; Schlattner, U.; Henry, H.; Snow, R.; Wallimann, T. Creatine transporters: A reappraisal. Mol. Cell. Biochem. 2004, 256, 407-424. DOI: https://doi.org/10.1023/B:MCBI.0000009886.98508.e7.
13. Wallimann, T.; Hemmer, W. III-2 creatine kinase in non-muscle tissues and cells. Mol. Cell. Biochem. 1994, 133/134, 193-220. https://doi.org/10.1007/BF01267955.
14. Bessman, S.; Carpenterm, C. The creatine-creatine phosphate energy shuttle. Ann. Rev. Biochem. 1985, 54, 831-862. DOI: https://doi.org/10.1146/annurev.bi.54.070185.004151.
15. Sweeney H. The importance of the creatine kinase reaction: the concept of metabolic capacitance. Med. Sci. Sports Exerc. 1994, 26(1), 30-36. DOI: https://doi.org/10.1249/00005768-199401000-00007.
16. Zuniga, J.; Housh, T.; Camic, C.; Hendrix, R.; Mielke, M.; Johnson, G.; Housh, D.; Schmidt, R. The effects of creatine monohydrate loading on anaerobic performance and one-repetition maximum strength. J. Strenght and Cond. Research. 2012, 26(6), 1651-1656.
17. Dobgenski, V.; Santos, M.; Campbell, B.; Kreider, R. Short-term creatine supplementation suppresses the cortisol response to a high-intensity swim-sprint workout. J. Nutr. Health Sci. 2014, 1(204), 8-10.
18. Devries, M.; Phillips, S. Creatine supplementation during resistance training in older adults- a meta-analysis. Med. Sci. Sports Exerc. 2014, 46(6), 1194-1203.
19. Antonio, J.; Ciccone, V. The effects of pre versus post workout supplementation of creatine monohydrate on body composition and strength. J. Int. Soc. Sports Nutr. 2013, 10(36), 1-8. DOI: https://doi.org/10.1186/1550-2783-10-36.
20. Veggi, K.; Machado, M.; Koch, A.; Santana, S.; Oliveira, S.; Stec, M. Oral creatine supplementation augments the repeated bout effect. Int. J. Sport. Nutr. Exerc. Metab. 2013, 23, 378-387.
21. Kreider, R.; Wilborn, C.; Taylor, L.; Campbell, B.; Almada, A.; Collins, R.; Cooke, M.; Earnest, C.; Greenwood, M.; Kalman, D.; Kerksick, C.; Kleiner, S.; Leutholtz, B.; Lopez, H.; Lowery, L.; Mendel, R.; Smith, A.; Spano, M.; Wildman, R.; Willoughby, D.; Ziegenfuss, T.; Antonio, J. ISSN Exercise & sport nutrition review: Research & recommendations. J. Inter. Soc. Sports Nutr. 2010, 7(7), 1-43. DOI: https://doi.org/10.1186/1550-2783-7-7.
22. Wallimann, T. Mehr energie: mehr leistung - kreatin: Warum, wann und für wen?. Schw. Zeitschrift für Ernährungsmedizin. 2008, 5, 29-40.
23. Stec, M.; Rawson, E. Benefits of creatine supplementation for older adults. Braz. J. Biomotricity. 2010, 4(4), 215-226.
24. Kreider, R.; Jung, Y. Creatine supplementation in exercise, sport, and medicine. J. Exerc. Nutr. Biochem. 2011, 15 (2), 53-69. DOI: https://doi.org/10.5717/jenb.2011.15.2.53.
25. Aguiar, A.; Januário, R.; Junior, R.; Gerage, A.; Pina, F.; do Nascimento, M.; Padovani, C.; Cyrino, E. Lon-term creatine supplementation improves muscular performance during resistance training in older women. Eur. J. Appl. Physiol. 2013, 113, 987-996. DOI: https://doi.org/10.1007/s00421-012-2514-6.
26. Kim, H.; Kim, C.; Carpentier, A.; Poortmans, J. Studies on the safety of creatine supplementation. Amino Acids. 2011, 40(5), 1409-1418. DOI: https://doi.org/10.1007/s00726-011-0878-2.
27. Carrillo, P.; Gilli, M. Los efectos que produce la creatina en la performance deportiva. Invenio. 2011, 14(26), 101-115.
28. Cooper, R; Nacleiro, F; Allgrove, J; Jimenez, A. Creatine supplementation with specific view to exercise/sports performance: an update. J. Int. Soc. Sports Nutr. 2012, 9(33), 1-11. DOI: https://doi.org/10.1186/1550-2783-9-33.
29. Brosnan, M.; Edison, E.; da Silva, R.; Brosnan, J. New Insights into creatine function and synthesis. Advan. Enzyme Regul. 2007, 47, 252-260. DOI: https://doi.org/10.1016/j.advenzreg.2006.12.005.
30. Mesa, J.; Ruiz, J.; González-Gross, M.; Gutiérrez, A.; Castillo, M. Oral creatine supplementation and skeletal muscle metabolism in physical exercise. Sports Med. 2002, 32(14), 903-944. DOI: https://doi.org/10.2165/00007256-200232140-00003.
31. Persky, A.; Brazeau, G. Clinical Pharmacology of the dietary supplement creatine monohydrate. Pharmacol. Rev. 2001, 53, 161-176.
32. del Favero, S.; Roschel, H.; Artioli, G.; Ugrinowitsch, C.; Tricoli, V.; Costa, A.; Barroso, R.; Negreli, A.; Otaduy, M.; da Costa, C.; Lancha-Junior, A.; Gualano, B. Creatine but not betaine supplementation increases phosphorylcreatine content and strength performance. Amino Acids. 2012, 42, 2299-2305. DOI: https://doi.org/10.1007/s00726-011-0972-5.
33. Brault, J.; Towse, T.; Slade, J.; Meyer, R. Parallel increases in phosphocreatine and total creatine in human vastus lateralis muscle during creatine supplementation. Int. J. Sport. Nutr. Exerc. Metab. 2007, 17(6), 624-634.
34. Meyer R. Linear dependence of muscle phosphocreatine kinetics on total creatine content. Am. J. Physiol. 1989, 257, 1149-1157.
35. Jones, A.; Wilkerson, D.; Fulford, J. Influence of dietary creatine supplementation on muscle phosphocreatine kinetics during knee-extensor exercise in humans. Am. J. Physiol. Regul. Integr. Comp. Physiol. 2009, 296, 1078-1087. DOI: https://doi.org/10.1152/ajpregu.90896.2008.
36. Kemp G. Interpreting the Phosphocreatine time constant in aerobically exercising skeletal muscle. J. Appl. Physiol. 2009, 106(1), 350 (author replay 351). DOI: https://doi.org/10.1152/japplphysiol.91297.2008.
37. Allen, D.; Clugston, E.; Petersen, Y.; Röder, I.; Chapman, B.; Rudolf, R. Interactions between intracellular calcium and phosphate in intact mouse muscle during fatigue. J. Appl. Physiol. 2011, 111(2), 358-366. DOI: https://doi.org/10.1152/japplphysiol.01404.2010.
38. Davies, R.; Eston, R.; Fulford, J.; Rowlands, A.; Jones, A. Muscle damage alters the metabolic response to dynamic exercise in humans: A 31P-MRS study. J. Appl. Physiol. 2011,111(3), 782-790. DOI: https://doi.org/10.1152/japplphysiol.01021.2010.
39. Rico-Sanz, J. Creatine reduces human muscle PCr and pH decrements and Pi accumulation during low-intensity exercise. J. Appl. Physiol. 2000, 88, 1181-1191.
40. Santos, M.; López, P.; González, J.; Moreno, A.; Alonso, J.; Cabañas, M.; Pons, V.; Porta, J.; Arús, C. Efecto de la suplementación oral con monohidrato de creatina en el metabolismo energético muscular y en la composición corporal de sujetos que practican actividad física. Rev. Chil. Nutr. 2003, 30(1), 58-63. DOI: https://doi.org/10.4067/S0717-75182003000100008.
41. Yquel, R.; Arsac, L.; Thiaudiere, E.; Canioni, P.; Manier, G. Effect of creatine supplementation on phosphocreatine resynthesis, inorganic phosphate accumulation and pH during intermittent maximal Exercise. J. Sports Sci. 2002, 20, 427-437. DOI: https://doi.org/10.1080/026404102317366681.
42. Greenhaff, P.; Casey, A.; Short, A.; Harris, R.; Soderlund, K.; Hultman, E. Influence of oral creatine supplementation on muscle torque during repeated bouts of maximal voluntary exercise in man. Clin. Sci. 1993, 84, 565-571. DOI: https://doi.org/10.1042/cs0840565.
43. McConell, G.; Shinewell, J.; Stephens, T.; Stathis, C.; Canny, B.; Snow, R. Creatine supplementation reduces muscle inosine monophosphate during endurance exercise in humans. Med. Sci. Sports Exerc. 2005, 37, 2054-2061. DOI: https://doi.org/10.1249/01.mss.0000179096.03129.a4.
44. Li, J.; Wang, X.; Fraser, S.; Carey, M.; Wrigley, T.; McKenna, M. Effects of fatigue and training on sarcoplasmic reticulum ca2+ regulation in human skeletal muscle. J. Appl. Physiol. 2002, 92, 912-922. DOI: https://doi.org/10.1152/japplphysiol.00643.2000.
45. Scarpa, A.; Carafoli, E.; Papa, S. Ion motive ATPases: Structure, function and regulation. First Edition, New York Academy of Sciences: New York, 1992; pp 671.
46. Kindig, C.; Howlett, R.; Stary, C.; Walsh, B.; Hogan, M. Effects of acute creatine kinase inhibition on metabolism and tension development in isolated single myocytes. J. Appl. Physiol. 2005, 98, 541-549. DOI: https://doi.org/10.1152/japplphysiol.00354.2004.
47. Pulido, S.; Passaquin, A.; Leijendekker, W.; Challet, C.; Wallimann, T.; Ruëegg, U. Creatine supplementation improves intracellular Ca2+ handling and survival in mdx skeletal muscle cells. FEBS Letters. 1998, 439, 357-362. DOI: https://doi.org/10.1016/S0014-5793(98)01399-4.
48. Gallo, M.; MacLean, I.; Tyreman, N.; Martins, K.; Syrotuik, D.; Gordon, T.; Putman, C. Adaptive responses to creatine loading and exercise in fast-twitch rat skeletal muscle. Am. J. Physiol. Regul. Integr. Comp. Physiol. 2008, 294, 1319-1328. DOI: https://doi.org/10.1152/ajpregu.00631.2007.
49. Calderón-Rivera, A.; Vega, A.; Ávil,a G. Creatine supplementation upregulates excitation-contraction coupling in C2C12 Myotubes. J. Receptor Ligand Channel Res. 2010, 3, 63-71.
50. Yang, Y.; Fann, M.; Chang, W.; Tai, L.; Jiang, J.; Kao, L. Regulation of sodium-calcium exchanger activity by creatine kinase under energy-compromised conditions. J. Biol.Chem. 2010, 285(36), 28275-28285. DOI: https://doi.org/10.1074/jbc.M110.141424.
51. Louis, M.; Poortmans, J.; Francaux, M.; Berre, J.; Boisseau, N.; Brassine, E.; Cuthbertson, D.; Smith, K.; Babraj, J.; Waddell, T.; Rennie, M. No effect of creatine supplementation on human myofibrillar and sarcoplasmic protein synthesis after resistance exercise. Am. J. Physiol. Endocrinol. Metab. 2003, 285, 1089-1094. DOI: https://doi.org/10.1152/ajpendo.00195.2003.
52. Moon, A; Heywood, L; Rutherford, S; Cobbold, C. Creatine supplementation in the elderly: is resistance training really needed?. J. Nutr. Health Sci. 2015, 2(1), 103.
53. Volek, J.; Duncan, N.; Mazzetti, S.; Staron, R.; Putukian, M.; Gómez, A.; Pearson, D.; Fink, W.; Kraemer, W. Performance and muscle fiber adaptations to creatine supplementation and heavy resistance training. Med. Sci. Sports Exerc. 1999, 31, 1147-1156. DOI: https://doi.org/10.1097/00005768-199908000-00011.
54. Forbes, S; Waltz, X; Candow, D. Creatine timing on muscle mass and strength: appetizer or dessert?. Agro. Food Ind. Hi. Tech. 2014, 25(4), 19-21.
55. Willoughby, D.; Rosene, J. Effects of Oral Creatine and Resistance Training on Myosin Heavy Chain Expression. Med. Sci. Sports Exerc. 2001, 33(10), 1674-1681. DOI: https://doi.org/10.1097/00005768-200110000-00010.
56. Gualano, B; Macedo, A; Rodrigues, C; Roschel, H; Takayama, L; de Sá, A; Rodrigues, F; Rodrigues, R. Creatine supplementation and resistance training in vulnerable older women: a randomized double-blind placebo-controlled clinical trial. Exp. Gerontol. 2014, 53, 7-15. DOI: https://doi.org/10.1016/j.exger.2014.02.003.
57. Saremi, A.; Gharakhanloo, R.; Sharghi, S.; Gharaati, M.; Larijani, B.; Omidfar, K. Effects of Oral Creatine and Resistance Training on Serum Myostatin and GASP-1. Mol. Cell. Endocrinol. 2010, 317, 25-30. DOI: https://doi.org/10.1016/j.mce.2009.12.019.
58. Deldicque, L.; Theisen, D.; Bertrand, L.; Hespel, P.; Hue, L.; Francaux, M. Creatine Enhances Differentiation of Myogenic C2C12 Cells by Activating both p38 and Akt/PKB Pathways. Am. J. Physiol. Cell. Physiol. 2007, 293, 1263-1271. DOI: https://doi.org/10.1152/ajpcell.00162.2007.
59. O'Connor, R.; Steeds, C.; Wiseman, R.; Pavlath, G. Phosphocreatine as an Energy Source for Actin Cytoskeletal Rearrangements during Myoblast Fusion. J. Physiol. 2008, 586(12), 2841-2853. DOI: https://doi.org/10.1113/jphysiol.2008.151027.
60. Ohira, Y.; Matsuoka, Y.; Kawano, F.; Ogura, A.; Higo, Y.; Ohira, T.; Terada, M.; Oke, Y.; Nakai, N. Effects of Creatine and Its Analog, β-Guanidinopropionic Acid, on the Differentiation of and Nucleoli in Myoblasts. Biosci. Biotechnol. Biochem. 2011, 75(6), 1085-1089. DOI: https://doi.org/10.1271/bbb.100901.
61. Drummond, M.; Dreyer, H.; Fry, C.; Glynn, E.; Rasmussen, B. Nutritional and Contractile Regulation of Human Skeletal Muscle Protein Synthesis and mTORC1 Signaling. J. Appl. Physiol. 2009, 106(4), 1374-1384. DOI: https://doi.org/10.1152/japplphysiol.91397.2008.
62. Schiaffino, S.; Mammucari, C. Regulation of skeletal muscle growth by the igf1-akt/pkb pathway: insights from genetic models. Skeletal Muscle. 2011, 1(4): 1-14. DOI: https://doi.org/10.1186/2044-5040-1-4.
63. Deldicque, L.; Louis, M.; Theisen, D.; Nielens, H.; Dehoux, M.; Thissen, J.; Rennie, M.; Francaux, M. Increased IGF mRNA in human skeletal muscle after creatine supplementation. Med. Sci. Sports Exerc. 2005, 37(5), 731-736. DOI: https://doi.org/10.1249/01.MSS.0000162690.39830.27.
64. Mackenzie, M.; Hamilton, D.; Murray, J.; Taylor, P.; Baar, K. mVps34 is Activated following high-resistance contractions. J. Physiol. 2009, 587(1), 253-260. DOI: https://doi.org/10.1113/jphysiol.2008.159830.
65. Burke, D.; Candow, D.; Chilibeck, P.; MacNeil, L.; Roy, B.; Tarnopolsky, M.; Ziegenfuss, T. Effect of creatine supplementation and resistance-exercise training on muscle insulin-like growth factor in young adults. Int. J. Sport Nutr. Exerc. Metab. 2008, 18, 389-398.
66. Snow, R.; Wright, C.; Quick, M.; Garnham, A.; Watt, K.; Russell, A. The effects of acute exercise and creatine supplementation on akt signalling in human skeletal muscle. Proc. Aust. Physiol. Society. 2008, 39, 92P.
67. Safdar, A.; Yardley, N.; Snow, R.; Melov, S.; Tarnopolsky, M. Global and targeted gene expression and protein content in skeletal muscle of young men following short-term creatine monohydrate supplementation. Physiol. Genomics. 2008, 32, 219-228. DOI: https://doi.org/10.1152/physiolgenomics.00157.2007.
68. Parise, G.; Mihic, S.; MacLennan, D.; Yarasheski, K.; Tarnopolsky, M. Effects of acute creatine monohydrate supplementation on leucine kinetics and mixed-muscle protein synthesis. J. Appl. Physiol. 2001, 91, 1041-1047.
69. Paddon-Jones, D.; Børsheim, E.; Wolfe, R. Potential ergogenic effects of arginine and creatine supplementation. J. Nutr. 2004, 134: 2888S-2894S.
70. Ponticos, M.; Lu, Q.; Morgan, J.; Hardie, D.; Partridge, T.; Carling, D. Dual regulation of the amp-activated protein kinase provides a novel mechanism for the control of creatine kinase in skeletal muscle. EMBO J. 1998, 17(6), 1688-1699. DOI: https://doi.org/10.1093/emboj/17.6.1688.
71. Dangott, B.; Schultz, E.; Mozdziak, P. Dietary creatine monohydrate supplementation increases satellite cell mitotic activity during compensatory hypertrophy. Int. J. Sports Med. 2000, 21, 13-16. DOI: https://doi.org/10.1055/s-2000-8848.
72. Olsen, S.; Aagaard, P.; Kadi, F.; Tufekovic, G.; Verney, J.; Olesen, J.; Suetta, C.; Kjær, M. Creatine supplementation augments the increase in satellite cell and myonuclei number in human skeletal muscle induced by strength training. J. Physiol. 2006, 573, 525-534. DOI: https://doi.org/10.1113/jphysiol.2006.107359.
73. Ziegenfuss, T.; Lemon, P.; Rogers, M.; Ross, R.; Yarasheski, K. Acute creatine ingestion: Effects on muscle volume, anaerobic power, fluid volumes, and protein turnover. Med. Sci. Sports. Exerc. 2000, 29(5), S127. DOI: https://doi.org/10.1097/00005768-199705001-00731.
74. Arazi, H.; Rahmaninia, F.; Hosseini, K; Asadi, A. Effects of short term creatine supplementation and resistance exercises on resting hormonal and cardiovascular responses. Sci. Sports. 2015, 30(2), 105-109. DOI: https://doi.org/10.1016/j.scispo.2014.03.006.
75. Kilduff, L.; Georgiades, E.; James, N. The Effects of creatine supplementation on cardiovascular, metabolic and thermoregulatory responses during exercise in the heat in endurance-trained humans. Int. J. Sport Nutr. Exerc. Metab. 2004, 14, 443-460.
76. Lopez, R.; Casa, D.; McDermott, B.; Ganio, M.; Armstrong, L.; Maresh, C. Does creatine supplementation hinder exercise heat tolerance or hydration status? a systematic review with meta-analyses. J. Athl. Train. 2009, 44(2), 215-223. DOI: https://doi.org/10.4085/1062-6050-44.2.215.
77. Haussinger, D.; Roth, E.; Lang, F.; Gerok, W. Cellular hydration state: An important determinant of protein catabolism in health and disease. Lancet. 1993, 341, 1330-1332.
78. Murray, R.; Granner, D.; Mayes, P.; Rodwell, V. Harper's illustrated biochemistry. 26th Edition. McGraw-Hill Medical: Toronto, 2003; pp 150. DOI: https://doi.org/10.1016/0140-6736(93)90828-5.
79. Deldicque, L.; Atherton, P.; Patel, R.; Theisen, D.; Nielens, H.; Rennie, M.; Francaux, M. Effects of resistance exercise with and without creatine supplementation on gene expression and cell signaling in human skeletal muscle. J. Appl. Physiol. 2008, 104, 371-378. DOI: https://doi.org/10.1152/japplphysiol.00873.2007.
80. Akimoto, T.; Pohnert, S.; Li, P.; Zhang, M.; Gumbs, C.; Rosenberg, P.; Williams, R.; Yan, Z. Exercise stimulates Pgc-1α transcription in skeletal muscle through activation of the p38 MAPK pathway. J. Biol. Chem. 2005, 280(20), 19587-19593. DOI: https://doi.org/10.1074/jbc.M408862200.
81. Al-Khalili, L.; Krämer, D.; Wretenberg, P.; Krook, A. Human skeletal muscle cell differentiation is associated with changes in myogenic markers and enhanced insulin-mediated MAPK and PKB phosphorylation. Acta. Physiol. Scand. 2004, 180, 395-403. DOI: https://doi.org/10.1111/j.1365-201X.2004.01259.x.
82. Perry, R.; Rudnicki, M. Molecular mechanisms regulating myogenic determination and differentiation. Front. Biosci. 2000, 5, 750-767. DOI: https://doi.org/10.2741/Perry.
83. Hespel, P.; Op't Eijnde, B.; Leemputte, M.; Ursø, B.; Greenhaff, P.; Labarque, V.; Dymarkowski, S.; Hecke, P.; Richter, E. Oral creatine supplementation facilitates the rehabilitation of disuse atrophy and alters the expression of muscle myogenic factors in humans. J. Physiol. 2001, 536(2), 625-633. DOI: https://doi.org/10.1111/j.1469-7793.2001.0625c.xd.
84. Lugaresi, R.; Leme, M.; Painelli, V.; Murai, I.; Roschel, H.; Sapienza, M.; Lancha-Junior, A.; Gualano, B. Does long-term creatine supplementation impair kidney function in resistance-trained individuals consuming a high-protein diet?. J. Int. Soc. Sports Nutr. 2013, 10(26), 1-6. DOI: https://doi.org/10.1186/1550-2783-10-26.
85. Willoughby, D.; Rosene, J. Effects of oral creatine and resistance training on myogenic regulatory factor expression. Med. Sci. Sports Exerc. 2003, 35(6), 923-929. DOI: https://doi.org/10.1249/01.MSS.0000069746.05241.F0.
86. Candow, D.; Zello, G.; Ling, B.; Farthing, J.; Chilibeck, P.; McLeod, K.; Harris, J.; Johnson, S. Comparison of creatine supplementation before versus after supervised resistance training in healthy older adults. Res. Sports Med. 2014, 22(1), 61-74. DOI: https://doi.org/10.1080/15438627.2013.852088.
87. de Salles, P.; Alves, V.; Ugrinowitsch, C.; Benatti, F.; Artioli, G.; Lancha-Junior, A.; Gualano, B.; Roschel, H. Creatine supplementation prevents acute strength loss induced by concurrent exercise. Eur. J. Appl. Physiol. 2014, 114(8), 1749-1755. DOI: https://doi.org/10.1007/s00421-014-2903-0.
Referencias
Williams, M.; Kreider, R.; Branch, J. Creatine; The Power Supplement. Leeds, UK. Human Kinetics. pp 6-7, 1999.
Pischel, I.; Gastner, T. Creatine – Its Chemical Synthesis, Chemistry and Legal Status. Subcell. Biochem. 2007. 46: 275-289.
Brosnan, M.; Brosnan, J. Creatine: Endogenous Metabolite, Dietary and Therapeutic Supplement. Annu. Rev. Nutr. 2007. 27: 241–261.
Stout, J.; Antonio, J.; Kalman, D. Essentials of Creatine in Sports and Health. Totowa, NJ. Humana Press Inc. pp 30-40, 2008.
da Silva, R.; Nissim, I.; Brosnan, M.; Brosnan, J. Creatine Synthesis: Hepatic Metabolism of Guanidinoacetate and Creatine in the Rat In Vitro and In Vivo. Am. J. Physiol. Endocrinol. Metab. 2009. 296: 256-261.
Uzzan, M.; Nechrebeki, J.; Zhou, P.; Labuza, T. Effect of Water Activity and Temperature on the Stability of Creatine during Storage. Drug Dev. Ind. Pharm. 2009. 35(8): 1003-1008.
Wyss, M.; Kaddurah-Daouk, R. Creatine and Creatinine Metabolism. Physiol. Rev. 2000. 80: 1107-1213.
Wallimann, T.; Tokarska-Schlattner, M.; Schlattner, U. The Creatine Kinase System and Pleiotropic Effects of Creatine. Amino Acids. 2011. 40: 1271-1296.
Snow, R.; Murphy, R. Creatine and the Creatine Transporter: A Review. Mol. Cell. Biochem. 2001. 224: 169-181.
Peral, M.; García-Delgado, M.; Calonge, M.; Durán, J.; De La Horra, M.; Wallimann, T.; Speer, O.; Ilundáin, A. Human, Rat and Chicken Small Intestinal Na+–Cl- Creatine Transporter: Functional, Molecular Characterization and Localization. J. Physiol. 2002. 545(1): 133-144.
Christie D. Functional Insights into the Creatine Transporter. Subcell. Biochem. 2007. 46: 99-118.
Speer, O.; Neukomm, L.; Murphy, R.; Zanolla, E.; Schlattner, U.; Henry, H.; Snow, R.; Wallimann, T. Creatine Transporters: A Reappraisal. Mol. Cell. Biochem. 2004. 256/257: 407-424.
Wallimann, T.; Hemmer, W. III-2 Creatine Kinase in Non-Muscle Tissues and Cells. Mol. Cell. Biochem. 1994. 133/134: 193-220.
Bessman, S.; Carpenterm, C. The Creatine-Creatine Phosphate Energy Shuttle. Ann. Rev. Biochem. 1985. 54: 831-862.
Sweeney H. The importance of the creatine kinase reaction: the concept of metabolic capacitance. Med. Sci. Sports Exerc. 1994. 26(1): 30-36.
Zuniga, J.; Housh, T.; Camic, C.; Hendrix, R.; Mielke, M.; Johnson, G.; Housh, D.; Schmidt, R. The effects of creatine monohydrate loading on anaerobic performance and one-repetition maximum strength. J. Strenght and Cond. Research. 2012. 26(6): 1651-1656.
Dobgenski, V.; Santos, M.; Campbell, B.; Kreider, R. Short-term creatine supplementation suppresses the cortisol response to a high-intensity swim-sprint workout. J. Nutr. Health Sci. 2014. 1(204): 8-10.
Devries, M.; Phillips, S. Creatine supplementation during resistance training in older adults- a meta-analysis. Med. Sci. Sports Exerc. 2014. 46(6): 1194-1203.
Antonio, J.; Ciccone, V. The effects of pre versus post workout supplementation of creatine monohydrate on body composition and strength. J. Int. Soc. Sports Nutr. 2013. 10(36): 1-8.
Veggi, K.; Machado, M.; Koch, A.; Santana, S.; Oliveira, S.; Stec, M. Oral creatine supplementation augments the repeated bout effect. Int. J. Sport. Nutr. Exerc. Metab. 2013. 23: 378-387.
Kreider, R.; Wilborn, C.; Taylor, L.; Campbell, B.; Almada, A.; Collins, R.; Cooke, M.; Earnest, C.; Greenwood, M.; Kalman, D.; Kerksick, C.; Kleiner, S.; Leutholtz, B.; Lopez, H.; Lowery, L.; Mendel, R.; Smith, A.; Spano, M.; Wildman, R.; Willoughby, D.; Ziegenfuss, T.; Antonio, J. ISSN Exercise & Sport Nutrition Review: Research & Recommendations. J. Inter. Soc. Sports Nutr. 2010. 7(7): 1-43.
Wallimann, T. Mehr Energie: Mehr Leistung – Kreatin: Warum, Wann und für Wen?. Schw. Zeitschrift für Ernährungsmedizin. 2008. 5: 29-40.
Stec, M.; Rawson, E. Benefits of Creatine Supplementation for Older Adults. Braz. J. Biomotricity. 2010. 4(4): 215-226.
Kreider, R.; Jung, Y. Creatine Supplementation in Exercise, Sport, and Medicine. J. Exerc. Nutr. Biochem. 2011. 15 (2): 53-69.
Aguiar, A.; Januário, R.; Junior, R.; Gerage, A.; Pina, F.; do Nascimento, M.; Padovani, C.; Cyrino, E. Lon-term creatine supplementation improves muscular performance during resistance training in older women. Eur. J. Appl. Physiol. 2013. 113: 987-996.
Kim, H.; Kim, C.; Carpentier, A.; Poortmans, J. Studies on the Safety of Creatine Supplementation. Amino Acids. 2011. 40 (5): 1409-1418.
Carrillo, P.; Gilli, M. Los Efectos que Produce la Creatina en la Performance Deportiva. Invenio. 2011. 14(26): 101-115.
Cooper, R; Nacleiro, F; Allgrove, J; Jimenez, A. Creatine supplementation with specific view to exercise/sports performance: an update. J. Int. Soc. Sports Nutr. 2012. 9(33): 1-11.
Brosnan, M.; Edison, E.; da Silva, R.; Brosnan, J. New Insights into Creatine Function and Synthesis. Advan. Enzyme Regul. 2007. 47: 252–260.
Mesa, J.; Ruiz, J.; González-Gross, M.; Gutiérrez, A.; Castillo, M. Oral Creatine Supplementation and Skeletal Muscle Metabolism in Physical Exercise. Sports Med. 2002. 32(14): 903-944.
Persky, A.; Brazeau, G. Clinical Pharmacology of the Dietary Supplement Creatine Monohydrate. Pharmacol. Rev. 2001. 53: 161-176.
del Favero, S.; Roschel, H.; Artioli, G.; Ugrinowitsch, C.; Tricoli, V.; Costa, A.; Barroso, R.; Negreli, A.; Otaduy, M.; da Costa, C.; Lancha-Junior, A.; Gualano, B. Creatine but not betaine supplementation increases phosphorylcreatine content and strength performance. Amino Acids. 2012. 42: 2299-2305.
Brault, J.; Towse, T.; Slade, J.; Meyer, R. Parallel Increases in Phosphocreatine and Total Creatine in Human Vastus Lateralis Muscle During Creatine Supplementation. Int. J. Sport. Nutr. Exerc. Metab. 2007. 17(6): 624-634.
Meyer R. Linear Dependence of Muscle Phosphocreatine Kinetics on Total Creatine Content. Am. J. Physiol. 1989. 257: 1149-1157.
Jones, A.; Wilkerson, D.; Fulford, J. Influence of Dietary Creatine Supplementation on Muscle Phosphocreatine Kinetics during Knee-Extensor Exercise in Humans. Am. J. Physiol. Regul. Integr. Comp. Physiol. 2009. 296: 1078–1087.
Kemp G. Interpreting the Phosphocreatine Time Constant in Aerobically Exercising Skeletal Muscle. J. Appl. Physiol. 2009. 106(1): 350; author replay 351.
Allen, D.; Clugston, E.; Petersen, Y.; Röder, I.; Chapman, B.; Rudolf, R. Interactions between Intracellular Calcium and Phosphate in Intact Mouse Muscle during Fatigue. J. Appl. Physiol. 2011. 111(2): 358-366.
Davies, R.; Eston, R.; Fulford, J.; Rowlands, A.; Jones, A. Muscle Damage Alters the Metabolic Response to Dynamic Exercise in Humans: a 31P-MRS Study. J. Appl. Physiol. 2011. 111(3): 782-790.
Rico-Sanz, J. Creatine Reduces Human Muscle PCr and pH Decrements and Pi Accumulation during Low-Intensity Exercise. J. Appl. Physiol. 2000. 88: 1181–1191.
Santos, M.; López, P.; González, J.; Moreno, A.; Alonso, J.; Cabañas, M.; Pons, V.; Porta, J.; Arús, C. Efecto de la suplementación oral con monohidrato de creatina en el metabolismo energético muscular y en la composición corporal de sujetos que practican actividad física. Rev. Chil. Nutr. 2003. 30(1): 58-63.
Yquel, R.; Arsac, L.; Thiaudiere, E.; Canioni, P.; Manier, G. Effect of Creatine Supplementation on Phosphocreatine Resynthesis, Inorganic Phosphate Accumulation and pH during Intermittent Maximal Exercise. J. Sports Sci. 2002. 20: 427–437.
Greenhaff, P.; Casey, A.; Short, A.; Harris, R.; Soderlund, K.; Hultman, E. Influence of Oral Creatine Supplementation on Muscle Torque during Repeated Bouts of Maximal Voluntary Exercise in Man. Clin. Sci. 1993. 84: 565-571.
McConell, G.; Shinewell, J.; Stephens, T.; Stathis, C.; Canny, B.; Snow, R. Creatine Supplementation Reduces Muscle Inosine Monophosphate during Endurance Exercise in Humans. Med. Sci. Sports Exerc. 2005. 37: 2054-2061.
Li, J.; Wang, X.; Fraser, S.; Carey, M.; Wrigley, T.; McKenna, M. Effects of Fatigue and Training on Sarcoplasmic Reticulum Ca2+ Regulation in Human Skeletal Muscle. J. Appl. Physiol. 2002. 92: 912–922.
Scarpa, A.; Carafoli, E.; Papa, S. Ion Motive ATPases: Structure, Function and Regulation. New York, NY. New York Academy of Sciences, First Edition. pp 671. 1992.
Kindig, C.; Howlett, R.; Stary, C.; Walsh, B.; Hogan, M. Effects of Acute Creatine Kinase Inhibition on Metabolism and Tension Development in Isolated Single Myocytes. J. Appl. Physiol. 2005. 98: 541-549.
Pulido, S.; Passaquin, A.; Leijendekker, W.; Challet, C.; Wallimann, T.; Ruëegg, U. Creatine Supplementation Improves Intracellular Ca2+ Handling and Survival in mdx Skeletal Muscle Cells. FEBS Letters. 1998. 439: 357-362.
Gallo, M.; MacLean, I.; Tyreman, N.; Martins, K.; Syrotuik, D.; Gordon, T.; Putman, C. Adaptive Responses to Creatine Loading and Exercise in Fast-Twitch Rat Skeletal Muscle. Am. J. Physiol. Regul. Integr. Comp. Physiol. 2008. 294: 1319-1328.
Calderón-Rivera, A.; Vega, A.; Ávil,a G. Creatine Supplementation Upregulates Excitation-Contraction Coupling in C2C12 Myotubes. J. Receptor Ligand Channel Res. 2010. 3: 63–71.
Yang, Y.; Fann, M.; Chang, W.; Tai, L.; Jiang, J.; Kao, L. Regulation of Sodium-Calcium Exchanger Activity by Creatine Kinase under Energy-Compromised Conditions. J. Biol. Chem. 2010. 285(36): 28275–28285.
Louis, M.; Poortmans, J.; Francaux, M.; Berre, J.; Boisseau, N.; Brassine, E.; Cuthbertson, D.; Smith, K.; Babraj, J.; Waddell, T.; Rennie, M. No Effect of Creatine Supplementation on Human Myofibrillar and Sarcoplasmic Protein Synthesis after Resistance Exercise. Am. J. Physiol. Endocrinol. Metab. 2003. 285: 1089-1094.
Moon, A; Heywood, L; Rutherford, S; Cobbold, C. Creatine supplementation in the elderly: is resistance training really needed?. J. Nutr. Health Sci. 2015. 2(1): 103.
Volek, J.; Duncan, N.; Mazzetti, S.; Staron, R.; Putukian, M.; Gómez, A.; Pearson, D.; Fink, W.; Kraemer, W. Performance and Muscle Fiber Adaptations to Creatine Supplementation and Heavy Resistance Training. Med. Sci. Sports Exerc. 1999. 31: 1147-1156.
Forbes, S; Waltz, X; Candow, D. Creatine timing on muscle mass and strength: appetizer or dessert?. Agro. Food Ind. Hi. Tech. 2014. 25(4): 19-21.
Willoughby, D.; Rosene, J. Effects of Oral Creatine and Resistance Training on Myosin Heavy Chain Expression. Med. Sci. Sports Exerc. 2001. 33(10): 1674-1681.
Gualano, B; Macedo, A; Rodrigues, C; Roschel, H; Takayama, L; de Sá, A; Rodrigues, F; Rodrigues, R. Creatine supplementation and resistance training in vulnerable older women: a randomized double-blind placebo-controlled clinical trial. Exp. Gerontol. 2014. 53: 7-15.
Saremi, A.; Gharakhanloo, R.; Sharghi, S.; Gharaati, M.; Larijani, B.; Omidfar, K. Effects of Oral Creatine and Resistance Training on Serum Myostatin and GASP-1. Mol. Cell. Endocrinol. 2010. 317: 25-30.
Deldicque, L.; Theisen, D.; Bertrand, L.; Hespel, P.; Hue, L.; Francaux, M. Creatine Enhances Differentiation of Myogenic C2C12 Cells by Activating both p38 and Akt/PKB Pathways. Am. J. Physiol. Cell. Physiol. 2007. 293: 1263-1271.
O’Connor, R.; Steeds, C.; Wiseman, R.; Pavlath, G. Phosphocreatine as an Energy Source for Actin Cytoskeletal Rearrangements during Myoblast Fusion. J. Physiol. 2008. 586(12): 2841–2853.
Ohira, Y.; Matsuoka, Y.; Kawano, F.; Ogura, A.; Higo, Y.; Ohira, T.; Terada, M.; Oke, Y.; Nakai, N. Effects of Creatine and Its Analog, β-Guanidinopropionic Acid, on the Differentiation of and Nucleoli in Myoblasts. Biosci. Biotechnol. Biochem. 2011. 75(6): 1085-1089.
Drummond, M.; Dreyer, H.; Fry, C.; Glynn, E.; Rasmussen, B. Nutritional and Contractile Regulation of Human Skeletal Muscle Protein Synthesis and mTORC1 Signaling. J. Appl. Physiol. 2009. 106(4): 1374-1384.
Schiaffino, S.; Mammucari, C. (2011). Regulation of Skeletal Muscle Growth by the IGF1-Akt/PKB Pathway: Insights from Genetic Models. Skeletal Muscle 1(4): 1-14.
Deldicque, L.; Louis, M.; Theisen, D.; Nielens, H.; Dehoux, M.; Thissen, J.; Rennie, M.; Francaux, M. Increased IGF mRNA in Human Skeletal Muscle after Creatine Supplementation. Med. Sci. Sports Exerc. 2005. 37(5): 731-736.
Mackenzie, M.; Hamilton, D.; Murray, J.; Taylor, P.; Baar, K. mVps34 is Activated Following High-Resistance Contractions. J. Physiol. 2009. 587(1): 253–260.
Burke, D.; Candow, D.; Chilibeck, P.; MacNeil, L.; Roy, B.; Tarnopolsky, M.; Ziegenfuss, T. Effect of Creatine Supplementation and Resistance-Exercise Training on Muscle Insulin-Like Growth Factor in Young Adults. Int. J. Sport Nutr. Exerc. Metab. 2008. 18: 389-398.
Snow, R.; Wright, C.; Quick, M.; Garnham, A.; Watt, K.; Russell, A. The Effects of Acute Exercise and Creatine Supplementation on Akt Signalling in Human Skeletal Muscle. Proc. Aust. Physiol. Society. 2008. 39: 92P.
Safdar, A.; Yardley, N.; Snow, R.; Melov, S.; Tarnopolsky, M. Global and Targeted Gene Expression and Protein Content in Skeletal Muscle of Young Men Following Short-term Creatine Monohydrate Supplementation. Physiol. Genomics. 2008. 32: 219-228.
Parise, G.; Mihic, S.; MacLennan, D.; Yarasheski, K.; Tarnopolsky, M. Effects of Acute Creatine Monohydrate Supplementation on Leucine Kinetics and Mixed-Muscle Protein Synthesis. J. Appl. Physiol. 2001. 91: 1041-1047.
Paddon-Jones, D.; Børsheim, E.; Wolfe, R. Potential Ergogenic Effects of Arginine and Creatine Supplementation. J. Nutr. 2004. 134: 2888S-2894S.
Ponticos, M.; Lu, Q.; Morgan, J.; Hardie, D.; Partridge, T.; Carling, D. Dual Regulation of the AMP-Activated Protein Kinase Provides a Novel Mechanism for the Control of Creatine Kinase in Skeletal Muscle. EMBO J. 1998. 17(6): 1688-1699.
Dangott, B.; Schultz, E.; Mozdziak, P. Dietary Creatine Monohydrate Supplementation Increases Satellite Cell Mitotic Activity during Compensatory Hypertrophy. Int. J. Sports Med. 2000. 21: 13-16.
Olsen, S.; Aagaard, P.; Kadi, F.; Tufekovic, G.; Verney, J.; Olesen, J.; Suetta, C.; Kjær, M. Creatine Supplementation Augments the Increase in Satellite Cell and Myonuclei Number in Human Skeletal Muscle Induced by Strength Training. J. Physiol. 2006. 573: 525-534.
Ziegenfuss, T.; Lemon, P.; Rogers, M.; Ross, R.; Yarasheski, K. Acute Creatine Ingestion: Effects on Muscle Volume, Anaerobic Power, Fluid Volumes, and Protein Turnover. Med. Sci. Sports. Exerc. 2000. 29(5): S127.
Arazi, H.; Rahmaninia, F.; Hosseini, K; Asadi, A. Effects of short term creatine supplementation and resistance exercises on resting hormonal and cardiovascular responses. Sci. Sports. 2015. 30(2): 105-109.
Kilduff, L.; Georgiades, E.; James, N. The Effects of Creatine Supplementation on Cardiovascular, Metabolic and Thermoregulatory Responses during Exercise in the Heat in Endurance-Trained Humans. Int. J. Sport Nutr. Exerc. Metab. 2004. 14: 443-460.
Lopez, R.; Casa, D.; McDermott, B.; Ganio, M.; Armstrong, L.; Maresh, C. Does Creatine Supplementation Hinder Exercise Heat Tolerance or Hydration Status? A Systematic Review with Meta-Analyses. J. Athl. Train. 2009. 44(2): 215-223.
Haussinger, D.; Roth, E.; Lang, F.; Gerok, W. Cellular Hydration State: An Important Determinant of Protein Catabolism In Health And Disease. Lancet. 1993. 341: 1330-1332.
Murray, R.; Granner, D.; Mayes, P.; Rodwell, V. Harper’s Illustrated Biochemistry 26th Edition. Toronto, ON. McGraw-Hill Medical. pp 150, 2003.
Deldicque, L.; Atherton, P.; Patel, R.; Theisen, D.; Nielens, H.; Rennie, M.; Francaux, M. Effects of Resistance Exercise with and without Creatine Supplementation on Gene Expression and Cell Signaling in Human Skeletal Muscle. J. Appl. Physiol. 2008. 104: 371-378.
Akimoto, T.; Pohnert, S.; Li, P.; Zhang, M.; Gumbs, C.; Rosenberg, P.; Williams, R.; Yan, Z. Exercise Stimulates Pgc-1α Transcription in Skeletal Muscle through Activation of the p38 MAPK Pathway. J. Biol. Chem. 2005. 280(20): 19587–19593.
Al-Khalili, L.; Krämer, D.; Wretenberg, P.; Krook, A. Human Skeletal Muscle Cell Differentiation is Associated with Changes in Myogenic Markers and Enhanced Insulin-Mediated MAPK and PKB Phosphorylation. Acta. Physiol. Scand. 2004. 180: 395–403.
Perry, R.; Rudnicki, M. Molecular Mechanisms Regulating Myogenic Determination and Differentiation. Front. Biosci. 2000. 5: 750-767.
Hespel, P.; Op‘t Eijnde, B.; Leemputte, M.; Ursø, B.; Greenhaff, P.; Labarque, V.; Dymarkowski, S.; Hecke, P.; Richter, E. Oral Creatine Supplementation Facilitates The Rehabilitation of Disuse Atrophy and Alters The Expression of Muscle Myogenic Factors In Humans. J. Physiol. 2001. 536(2): 625-633.
Lugaresi, R.; Leme, M.; Painelli, V.; Murai, I.; Roschel, H.; Sapienza, M.; Lancha-Junior, A.; Gualano, B. Does long-term creatine supplementation impair kidney function in resistance-trained individuals consuming a high-protein diet?. J. Int. Soc. Sports Nutr. 2013. 10(26): 1-6.
Willoughby, D.; Rosene, J. Effects of Oral Creatine and Resistance Training on Myogenic Regulatory Factor Expression. Med. Sci. Sports Exerc. 2003. 35(6): 923-929.
Candow, D.; Zello, G.; Ling, B.; Farthing, J.; Chilibeck, P.; McLeod, K.; Harris, J.; Johnson, S. Comparison of creatine supplementation before versus after supervised resistance training in healthy older adults. Res. Sports Med. 2014. 22(1): 61-74.
de Salles, P.; Alves, V.; Ugrinowitsch, C.; Benatti, F.; Artioli, G.; Lancha-Junior, A.; Gualano, B.; Roschel, H. Creatine supplementation prevents acute strength loss induced by concurrent exercise. Eur. J. Appl. Physiol. 2014. 114(8): 1749-1755.
Cómo citar
IEEE
ACM
ACS
APA
ABNT
Chicago
Harvard
MLA
Turabian
Vancouver
Descargar cita
Licencia
Los autores/as conservarán sus derechos de autor y garantizarán a la revista el derecho de primera publicación de su obra, el cuál estará simultáneamente sujeto a la Licencia de reconocimiento de Creative Commons (CC. Atribución 4.0) que permite a terceros compartir la obra siempre que se indique su autor y su primera publicación en esta revista.
Los autores/as podrán adoptar otros acuerdos de licencia no exclusiva de distribución de la versión de la obra publicada (p. ej.: depositarla en un archivo telemático institucional o publicarla en un volumen monográfico) siempre que se indique la publicación inicial en esta revista.
Se permite y recomienda a los autores/as difundir su obra a través de Internet (p. ej.: en archivos telemáticos institucionales o en su página web) antes y durante el proceso de envío, lo cual puede producir intercambios interesantes y aumentar las citas de la obra publicada. (Véase El efecto del acceso abierto).